Following recent U.S. Food and Drug Administration calls for food and dietary supplement manufacturers to include more information about caffeine on product labels, the Consumer Healthcare Products Association (CHPA)—a member-based association representing manufacturers and distributors of overthe- counter medicines and dietary supplements—has approved new voluntary labeling guidelines for dietary supplements that contain caffeine. According to CHPA Vice President of Regulatory & Scientific Affairs Barbara Kochanowski, the new guidelines will help “ensure transparency” in labeling and provide information consumers need to “safely choose and use a dietary supplement.”

The new guidelines address the labeling, packaging and promotion of caffeinecontaining supplements and specifically require CHPA members to (i) disclose total caffeine content per serving, (ii) include a statement on supplements that contain more than 100 mg of caffeine per serving indicating that the product is not intended for children or caffeine-sensitive individuals and that pregnant or nursing women should consult a health care professional before using the product, and (iii) stipulate that caffeine-containing supplements not be marketed, advertised or promoted in combination with alcohol. See CHPA News Release, June 21, 2013.